Showing results by publisher "--Tyson Hanks" in Pharmacology

With triplet eight-year-old daughters, I don't get four-hour study blocks in a quiet corner of the library. I get an hour here or 15 minutes there. This book is for those commuters, busy parents, and working students who need a "fit it in" approach to studying pharmacology. This book has multiple rapid-fire questions, answers, rationales, and mnemonics that you can do alone or with a partner to help you understand pharmacology better and remember the content longer.

The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.

Clinical pharmacology is often one of the most challenging topics for healthcare professionals. This is a compilation of my favorite case scenarios, drug interactions, and clinical pearls from my practice as a clinical pharmacist. This book is a perfect piece of education for pharmacists, nurse practitioners, physicians, physician assistants, and nurses who are looking to pick up real-life clinical practice pearls about medication management. It is ideal for the new professional or student trying to gain more confidence when it comes to medication management.

For many, drug interactions are one of the most frustrating challenges in family medicine, geriatrics, and ambulatory care practice. Even if one is up to speed on what drugs interact with one another, it is often unknown how to manage that specific interaction. Throughout the book, I share some of my management tips and pearls to help you feel more comfortable with managing drug interactions. This book is a perfect piece of education for pharmacists, nurse practitioners, physicians, physician assistants, and nurses who are looking to pick up clinical, real-world practice pearls.

Psilocybin, a natural psychedelic found in certain mushrooms, is emerging as a breakthrough in mental health. Once sidelined due to stigma, it now leads research for treating PTSD, depression, anxiety, and aiding addiction recovery. Early studies show it allows deep introspection, helping people process trauma and negative thought patterns. This guide explores the transformative experiences psilocybin offers, where the mind unlocks kaleidoscopic dimensions, space bends, and time becomes fluid.

Bradwel reminds us that the centenary of this apparent "wonder drug" should be no cause for celebration. Insulin often remains inaccessible to those who need it most: elusive prescriptions, uneven availability and sky-high prices result in rationing and desperate do-it-yourself research and development. In the face of bootstraps rhetoric and "Pharma Bro" capitalists, patients across the world are left to fend for themselves. There is a long way to go in the twenty-first century until insulin truly fulfills the extraordinary promises made by its discovery.

Almost daily, headlines announce newly discovered links between cancers and their genetic causes. Science journalist Jessica Wapner vividly relates the backstory behind those headlines, reconstructing the crucial breakthroughs, explaining the science behind them, and giving due to the dozens of researchers, doctors, and patients whose curiosity and determination restored the promise of a future to the more than 50,000 people diagnosed each year with chronic myeloid leukemia (CML).

Say Why to Drugs investigates the science behind recreational drugs - debunking common myths and misconceptions, as well as containing the most recent scientific research. Looking at a range of drugs, this book provides a clear understanding of how drugs work and what they're really doing to your mind and body. Along the way you will find out why ketamine is on the WHO's list of essential medicines, why some researchers hope MDMA could treat PTSD, and much more.

Cannabis is at the very beginning of a craft and educational renaissance. It is emerging from the legislative shadows and a second awakening is occurring: people are proactively seeking information about how to properly consume and enjoy it. And cannabis is a wildly diverse product, even more so than alcohol. The Leafly Guide to Cannabis provides all the best tips to navigating this growing market in a definitive guide that will enhance every user's enjoyment and high.

Between Hope and Fear tells the remarkable story of vaccine-preventable infectious diseases and their social and political implications. While detailing the history of vaccine invention, Michael Kinch reveals the ominous reality that our victories against vaccine-preventable diseases are not permanent - and could easily be undone. Between Hope and Fear relates the remarkable intersection of science, technology, and disease that has helped eradicate many of the deadliest plagues known to man.

One hundred years after a milestone medical discovery, Insulin: The Crooked Timber tells the story of how insulin was transformed from what one clinician called "thick brown muck" into the very first drug to be produced using genetic engineering, one which would earn the founders of the US biotech company Genentech a small fortune. Taking the listener on a fascinating journey, starting with the discovery of insulin in the 1920s through to the present day, the book reveals a story of monstrous egos, toxic career rivalries, and a few unsung heroes.

Blockbuster drugs - each of which generates more than a billion dollars a year in revenue - have revolutionized the industry since the early 1980s, when sales of Tagamet alone transformed a minor Philadelphia-based firm into the world's ninth-largest pharmaceutical company. In Blockbuster Drugs, Jie Jack Li tells the fascinating stories behind the discovery and development of these highly lucrative medicines, while also exploring the tumult the industry now faces as the "patent cliff" nears.

The pharmaceutical industry is broken. A system that was designed to drive innovation and patient care has been relentlessly distorted to drive up profits. Medicines have become nothing more than financial assets. Sick Money argues that the way medicines are developed and paid for is no longer working. In this book, investigative journalist Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back.

AudioLearn Crash Courses presents PTCE - Complete Review for the Pharmacy Technician Certification Exam. Developed by experienced professors and professionally narrated for easy listening, this course is a valuable tool when preparing for your PTCE or Pharmacy Technician Certification Exam. The audio is focused and high-yield, covering the most important topics you need to know to succeed on your test.

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health, while contributing trillions of dollars to the global economy. In spite of these past successes - and indeed because of them - our ability to deliver new medicines may be quickly coming to an end. Moving from the 20th century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them.

Medicines are arguably the most highly regulated - and cost-inflated - products in the United States. The discovery, development, manufacturing, and distribution of medicines is carried out by an ever more complex and crowded set of industries, each playing a part in a larger “pharmaceutical enterprise” seeking to maximize profits. But this was not always the case. The Price of Health is the reveals the story of how the pharmaceutical enterprise took shape and led to the present crisis.

The 20th century saw a remarkable upsurge of research on drugs, with major advances in the treatment of bacterial and viral infections, heart disease, stomach ulcers, cancer, and metal illnesses. These, along with the introduction of the oral contraceptive, have altered all of our lives. There has also been an increase in the recreational use and abuse of drugs in the Western world. This Very Short Introduction, in its second edition, gives a nontechnical account of how drugs work in the body.

Do you find yourself overwhelmed by the complexity of pediatric pharmacology? Are you searching for a more engaging way to learn and retain critical medication information? Looking for a resource that makes pediatric medications actually stick in your memory? In "Pediatric Meds Made Easy," Callie Parker transforms complex medication information into memorable rhymes that stick. This innovative guide combines evidence-based pharmacology with creative poetry, making it the perfect companion for nursing students, healthcare providers, and anyone working in pediatric care.

The inside story of the race to develop Ozempic – the world's first truly effective and safe obesity drug – and its potentially revolutionary effects on public health, and our deeper culture and values. Weight loss medications like Ozempic and Wegovy were born from a breakthrough in type 2 diabetes treatment, tricking users into feeling full. But these drugs are proving so transformative that entire industries are being disrupted. The story of obesity drugs, however, goes far beyond billion dollar profits.